Cancer-Associated Thromboembolic Disease and the Evolution of Management.

Venous thromboembolism remains a serious complication for patients with cancer, affecting survival and disrupting cancer-directed therapy. Cancer-associated thrombosis unfolds due to a combination of factors, including systemic inflammation and intri…

Preview only. Read the full abstract at the source